PathologybioRxivPreprint
Targeting Circulating FABP4 Ameliorates Obesity-Associated Hepatic Steatosis
Xingshan Jiang, Anthony M. Avellino, Jianyu Yu…·Bing Li
This study identifies circulating FABP4 as a mediator of adipocyte-hepatocyte lipid crosstalk in obesity and shows that targeting it with a monoclonal antibody reduces hepatic steatosis in mouse models.
DOI 10.64898/2026.01.24.701451